CORCEPT THERAPEUTICS INC Increase (Decrease) in Accounts and Other Receivables
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Accounts and Other Receivables of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2021-02-23
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for the quarter ending 2019-12-31 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for the quarter ending 2019-09-30 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for the quarter ending 2019-06-30 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for the quarter ending 2019-03-31 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for fiscal 2020 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for fiscal 2019 was $0.00.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for fiscal 2018 was -$12.90M, a 200.00% decline from fiscal 2017.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts and other receivables for fiscal 2017 was $12.90M.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $0.00 derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | -$20.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | -$20.00K derived: sum of 3 quarters · filed 2021-02-23 | -$12.90M 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$20.00K derived: sum of 2 quarters · filed 2019-11-07 | -$12.90M 10-Q · filed 2019-11-07 | -$12.96M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$12.90M 10-Q · filed 2019-08-01 | -$12.96M derived: sum of 3 quarters · filed 2020-02-24 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | -$12.88M 10-Q · filed 2019-05-09 | -$12.95M derived: sum of 2 quarters · filed 2020-02-24 | $20.00K derived: sum of 3 quarters · filed 2020-02-24 | $20.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $12.90M derived: sum of 2 quarters · filed 2020-02-24 | $12.90M derived: sum of 3 quarters · filed 2020-02-24 | $12.90M 10-K · filed 2020-02-24 |
| 2017-09-30 | $12.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $12.96M derived: sum of 2 quarters · filed 2018-11-02 | $12.96M 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |